Chronopharmacological aspects of PK/PD modelling

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 10, 1997, Pages 458-464

  Lemmer, B ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

Chronopharmacokinetics; Chronopharmacology; Circadian rhythms; PK PD modelling

Indexed keywords

ANTIHYPERTENSIVE AGENT; NIFEDIPINE; OXPRENOLOL; PROPRANOLOL; UNINDEXED DRUG; VERAPAMIL;

BLOOD PRESSURE; CHRONOPHARMACOLOGY; CIRCADIAN RHYTHM; DOSE RESPONSE; HEART RATE; HUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHRONOTHERAPY; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HUMANS; HYPERTENSION; MODELS, BIOLOGICAL;

EID: 0030832854     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Aschoff J l 963 Gesetzmäßigkeiten der biologischen Tagesperiodik. Dtsch Med Wochenschr 88: 1930
2. Aschoff J 1965 Circadian Clocks. North-Holland, Amsterdam
3. Asmar R, Hughes Ch, Pannier B. Daou J. Safar ME 1987 Duration of action of bisuprolol after cessation of a 4 weeks treatment and its influence on pulse wave velocity and aortic diameter: a pilot study in hypertensive patients. Eur Mean J 8 (Suppl M): 115-120
4. Bruguerolie B. Bouvenot G, Bartolin R, Manolis J 1988 Chronopharmacocinetique de la digoxine chez le sujet de plus de soixante-dix ans. Therapie 43:251-253
5. Cugini P, Kawasaki T, DiPalma L, Antonicoli S, Battisti P, Coppola A. Leone G 1989 Preventive distinction of patients with primary or secondary hypertension by discriminant analysis of chronobiologic parameters on 24-h blood pressure patterns. Jpn Circ J 53: 1363-1370
6. Fogari R, Malocca E, Tettamanti F, Tettamanti F, Gnemmi AE, Milani M 1993 Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24-h ambulatory monitoring. Br J Clin Pharmacol 35: 51-54
7. Coo RH, Moore JG, Greenberg E, Alazraki NP 1987 Circadian variation in gastric emptying of meals in humans. Gastroenterology 93: 515-518
8. Could BA, Mann S, Kieso H, Balasubramanian V, Raftery EB 1982 The 24-hour ambulatory blood pressure profile with verapamil. Circulation 65: 22-27
9. Gould BA. Raftery EB 1991 Twenty-four-hour blood pressure control: an intrarterial review. Chronobiol Int 8: 495-505
10. Greminger P, Suter PM, Holm D, Kobelt R, Vetter W 1994 Morning versus evening administration of nifedipinc gastrointestinal therapeutic system in the management of essential hypertension. Clin Invest 72: 864-869
11. Hla KK, Latham AN, Henry JA 1992 Influence of time of administration on verapamil pharmacokinetics. Clin Pharmacol Ther 51: 366-370
12. Jespersen CM, Frederiksen M, Hansen JF, Klitgeard NA, Sorum C 1989 Circadian variation in the pharmacokinetics of verapamil. Eur J Clin Pharmacol 37: 613-615
13. Koopmans R, Oosterhuis B, Karemaker JM, Weiner J, van Boxtel CJ 1993 The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man. Eur J Clin Pharmacol 44: 171-176
14. Langner B, Lemmer B 1988 Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur J Clin Pharmacol 33: 619-624
15. Lemmer B 1989 Temporal aspects in the effetcs of cardiovascular active drugs. In: Lemmer B (ed) Chronopharmacology - Cellular and Biochemical Aspects. Marcel Dekker, New York, pp 525-542
16. Lemmer B 1995 Timing of cardiovascular medications - pitfalls and challenges. Br J Cardiol 2: 303-309
17. Lemmer B 1996a Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from the chronobiological point of view. Blood Pressure Monitoring 1: 161-169
18. Lemmer B 1996b Circadian rhythm in blood pressure: Signal transduction, regulatory mechanisms and cardiovascular medication. In: Lemmer B (ed) From the Biological Clock to Chronopharmacology. medpharm Publ, Stuttgart, pp 9l-117
19. Lemmer B, Bruguerolle B 1994 Chronopharmacokinetics - are they clinically relevant? Clin Pharmacokin 26: 419-427
20. Lemmer B, Mattes A, Bohm M, Ganten D 1993 Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 22: 97-101
21. Lemmer B, Nold G 1991 Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol 32: 627-629
22. Lemmer B, Nold G, Behne S, Kaiser R 199lc Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol Int 8: 485-494
23. lemmer B, Portaluppi F 1997 Chronopharmacology of cardiovascular diseases. In: Redfern P, Lemmer B (eds) Handbook of Experimental Pharmacology, Vol 125: Physiology and Pharmacology of Biological Rhythms. Springer, Heidelberg, pp 251-297
24. Lemmer B, Sasse U. Witte K, Hopf R 1994 Pharmacokinetics and cardiovascular effects of a new sustained-release formulation of diltiazem. Naunyn-Schmicdebcrg's Arch Pharmacol 349: R141
25. Lemmer B, Scheidel B, Behne S 1991b Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs: propranolol. organic nitrates, nifedipine. Ann NY Acad Sci 618:166-181
26. Lemmer B, Scheidel B, Blume H, Becker HJ 1991 a Clinical Chronopharmacology of oral sustained-release isosorbide-5-mononitratc in healthy subjects. Eur J Clin Pharmacol 40: 71-75
27. Mancia G 1993 Autonomic modulation of the cardiovascular system during sleep. N Engl J Med 328: 347-349
28. Meilhac B. Mallion JM, Carre A, Chanudet X, Poggi L, Gosse P, Dallo-chio M 1992 Étude de l'influence de l'horaire de la prise sur 1'effet antihypertenseur et la tolérance de la nitrendipine chez des patients hypertendus essentiell légere à modérés. Therapie 47: 205-210
29. Mengden T. Binswanger B, Gruene S 1992 Dynamics of drug compliance and 24-hour blood pressure control of once daily morning vs evening amlodipine. J Hypertens 10 (Suppl 4): S136
30. Middeke M. Kluglich M. Hokgreve H 1991 Chronopharmacology of captopril plus hydrochlorothiazidc in hypertension: morning versus evening dosing. Chronobiol Int 8; 506-510
31. Middeke M, Schrader J 1994 Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. Br Med J 308: 630-632
32. Nold G. Strobel G, Thomas-Morr M, Lemmer B 1996 Morgendliche versus abendliche Gabe von Amlodipin: Wirksamkeit und Einfluß auf das Blutdruckprofil primärer Hypertoniker. Nieren-Hochdruckkrkh 25: 120-121
33. Palatini P. Mos L. Mololese M. Mormino P, DelTorre M, Varotto L, Pavan E, Pessina AE 1993 Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol 31: 295-300
34. Palatini P, Racioppa A, Raule G, Zaninotti M, Penzo M, Pessina AC 1992 Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 52: 378-383
35. Panza JA, Epstein SE, Quyyumi M 1991 Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 325: 986-990
36. Perloff D. Sokolow M. Cowan R 1983 The prognostic value of ambulatory blood pressures. JAMA 249:2792-2798
37. Ponaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C 1995 Time-dependent effect of isradipine on the nocturnal hypertension of chronic renal failure. Am J Hypertens 8:719-726
38. Pringle SD, Dunn FG, Tweddel AC et al 1992 Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy. Br Heart J 67: 377-382
39. Quyyumi M, Wright C, Mockus L Fox KM 1984 Effect of partial agonist activity in β-blockers in severe angina pectoris: a double-blind comparison of pindolol and atenolol. Br Med J 289:951-953
40. Scheidel B, Lemmer B 1991 Chronopharmacology of oral nitrates in healthy subjects. Chronobiol Im H: 409-419
41. Stanton A, O'Brien E 1994 Auswirkungen der Therapie auf das zirkadiane Blutdruckprofil. Kardiologie 3: 1-8
42. Umeda T. Naomi S, Iwsoka S. Inoue J. Sasaki M, Ideguchi Y, Sato T 1994 Timing for administration of an antihypertensive drug in the treatment of essential hypertension. Hypertension 23 (Suppl D): 1211-1214
43. Willich SN. Muller JE 1996 Triggering of acute coronary syndromes. Kluwer. Dordrecht. The Netherlands
44. Witte K. Lemmer B 1995 Free-running rhythms in blood pressure and heart rate in normotensive and transgenic hypertensive rats. Chronobiol Int 12: 237-247
45. Wine K, Lemmer B 1997 Rhythms in second mechanisms. In: Redfern P. Lemmer B (eds) Handbook of Experimental Pharmacology, Vol 125: Physiology and Pharmacology of Biological Rhythms. Springer. Heidelberg, pp 135-156
46. Wine K, Weisser K, Neubeck M, Mutschler E. Lehmann K, Hopf R, Lemmer B 1993 Cardiovascular effects, pharmacokinctics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 54: 177-186
47. Zuther P, Wine K, Lemmer B 1996 ABPM and CV SORT: an easy-to-use software package for detailed analysis of data from ambulatory blood pressure monitoring. Blood Pressure Monitoring 1: 347-354